AI News Sentiment & Analysis
Relmada Therapeutics, Inc. (RLMD) — AI News Sentiment & Analysis
3 recent AI analyses of Relmada Therapeutics, Inc. (RLMD) stock news and press releases, with sentiment and confidence scoring updated continuously.
Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes
BullishCorporate EventInclusion in the Russell 2000 and 3000 indexes will lead to automatic purchases by index-tracking funds, creating a demand shock for the stock. (Timing: Immediate to short-term, as index funds adjust portfolios post-reconstitution (effective after June 26, 2026).)Jun 29, 2026Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
BullishEarnings ReleaseInitiation of Phase 3 RESCUE registrational program for NDV-01, leveraging positive Phase 2 data and secured funding. (Timing: Mid-2026)May 12, 2026Relmada Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
BullishThe primary catalysts are the initiation of the Phase 3 RESCUE program for NDV-01 and initial 3-month data from this study. (Timing: Phase 3 initiation in mid-2026, with initial 3-month data expected by year-end 2026.)Mar 19, 2026
Want the full picture?
These are AI-read press-release catalysts. Sign up to see complete investment theses, valuation rationales, entry/exit strategies, and get real-time alerts.
Sign Up for FreeFrequently Asked Questions
Is Relmada Therapeutics, Inc. (RLMD) bullish or bearish right now?
AI Sentiment on RLMD: 3 Bullish.
What was the latest AI analysis for Relmada Therapeutics, Inc. (RLMD)?
The latest analysis was published on 6/29/2026 with the headline: "Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes".
How does Bekodia analyze Relmada Therapeutics, Inc. (RLMD) stock?
Bekodia uses advanced AI models to process Relmada Therapeutics, Inc. (RLMD) press releases and news in real-time, extracting sentiment, confidence scores, and key investment catalysts while filtering out market noise.